WeVote

Bill

Bill

SB 4161

USE/OCC TX-PRESCRIPTIONS

104th Regular Session Introduced by Laura Fine

SB 4161 addresses Illinois use and occupancy tax treatment for Texas-sourced prescriptions, potentially affecting cross-state pharmacy commerce and healthcare costs.

0
WeVote Research Nonpartisan
Bill Summary · SB 4161

Legislative bill overview

SB 4161 pertains to the use and occupancy tax treatment of Texas prescriptions in Illinois. The bill, introduced by Senator Laura Fine, appears to address tax implications or regulatory treatment of prescription medications obtained from or related to Texas in Illinois jurisdictions. At this early stage (first reading as of February 2026), the specific provisions are not yet publicly detailed.

Why is this important

Illinois residents and businesses that source prescriptions across state lines could face tax or regulatory clarity depending on the bill's provisions. This could affect healthcare costs, pharmacy operations, and interstate commerce in pharmaceutical services. Clarifying tax treatment of cross-state prescription transactions may impact revenue collection and consumer access to medications.

Potential points of contention

  • Whether out-of-state prescription purchases should be subject to Illinois use/occupancy taxes, which could increase costs for consumers buying from Texas pharmacies
  • Implementation challenges in tracking and enforcing tax collection on interstate prescription transactions
  • Potential conflicts with federal law regarding state taxation of interstate commerce and prescription drug regulation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.